Skip to content

Prospective cohort study of fractional exhaled nitric oxide combined with IFN-? in the first episode of wheezing in infants and young children

Prospective cohort study of fractional exhaled nitric oxide combined with IFN-? in the first episode of wheezing in infants and young children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125685
Enrollment
Unknown
Registered
2026-05-29
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wheezing and asthma in children

Interventions

Observation group:N/A

Sponsors

The Zhangzhou Municipal Hospital of Fujian Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.1 Years to 3 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 6 months and 3 years, with no gender restriction. 2. First episode of wheezing requiring hospitalization. 3. Admission within 72 hours after the onset of wheezing. 4. Written informed consent provided by the legal guardian.

Exclusion criteria

Exclusion criteria: 1 A documented history of asthma or two or more prior episodes of wheezing. 2 Presence of underlying diseases such as congenital heart disease, bronchopulmonary dysplasia (BPD), immunodeficiency, or inherited metabolic disorders. 3 Use of systemic glucocorticoids or immunomodulators within two weeks prior to admission. 4 Inability to complete fractional exhaled nitric oxide (FeNO) testing or poor cooperation with pulmonary function testing. 5 Legal guardian refuses to participate in the study or is unable to comply with follow-up requirements

Design outcomes

Primary

MeasureTime frame
Asthma diagnosis status;Number of wheezing recurrences;Hospitalization rate due to wheezing;Time to initiation and duration of inhaled corticosteroid (ICS) use;

Secondary

MeasureTime frame
FeNO dynamic trajectory subtypes;Baseline IFN-? level;Total IgE level;Peripheral blood eosinophil count;Results of 13 respiratory pathogen panel;Tidal breathing lung function parameters;IL-4,IL-13;

Countries

China

Contacts

Public ContactZhang Jiaxiang

The Zhangzhou Municipal Hospital of Fujian Province

zhangzhou363000@163.com+86 139 0694 2285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026